Publicaciones en colaboración con investigadores/as de Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (216)

2024

  1. A new mutation in the Parkinson's-related FBXO7 gene impairs mitochondrial and proteasomal function

    FEBS Journal

  2. Allosteric modulation of the CXCR4:CXCL12 axis by targeting receptor nanoclustering via the TMV-TMVI domain

    eLife, Vol. 13

  3. Beneficial Effect of Dimethyl Fumarate Drug Repositioning in a Mouse Model of TDP-43-Dependent Frontotemporal Dementia

    Antioxidants, Vol. 13, Núm. 9

  4. Clearance of β-amyloid mediated by autophagy is enhanced by MTORC1 inhibition but not AMPK activation in APP/PSEN1 astrocytes

    GLIA, Vol. 72, Núm. 3, pp. 588-606

  5. Enhancing Drug Discovery and Development through the Integration of Medicinal Chemistry, Chemical Biology, and Academia-Industry Partnerships: Insights from Roche’s Endocannabinoid System Projects

    Chimia, Vol. 78, Núm. 7-8, pp. 499-512

  6. GAP43 Located on Corticostriatal Terminals Restrains Novelty-Induced Hyperactivity in Mice

    Journal of Neuroscience, Vol. 44, Núm. 39

  7. Involvement of CB1 and CB2 receptors in neuroprotective effects of cannabinoids in experimental TDP-43 related frontotemporal dementia using male mice

    Biomedicine and Pharmacotherapy, Vol. 174

  8. The CB1 receptor interacts with cereblon and drives cereblon deficiency-associated memory shortfalls

    EMBO Molecular Medicine, Vol. 16, Núm. 4, pp. 755-783

  9. The mitochondrial Na+/Ca2+ exchanger NCLX is implied in the activation of hypoxia-inducible factors

    Redox Biology, Vol. 77

2023

  1. Altered Clock Gene Expression in Female APP/PS1 Mice and Aquaporin-Dependent Amyloid Accumulation in the Retina

    International Journal of Molecular Sciences, Vol. 24, Núm. 21

  2. Characterizing SOD1 mutations in Spain: The impact of genotype, age and sex in the natural history of the disease

    European Journal of Neurology, Vol. 30, Núm. 4, pp. 861-871

  3. Control of a hippocampal recurrent excitatory circuit by cannabinoid receptor-interacting protein Gap43

    Nature Communications, Vol. 14, Núm. 1

  4. Disease-modifying effects of cannabidiol, β-caryophyllene and their combination in Syn1-Cre/Scn1aWT/A1783V mice, a preclinical model of Dravet syndrome

    Neuropharmacology, Vol. 237

  5. Elafibranor upregulates the EMT-inducer S100A4 via PPARβ/δ

    Biomedicine and Pharmacotherapy, Vol. 167

  6. Endocannabinoid signaling in glioma

    GLIA, Vol. 71, Núm. 1, pp. 127-138

  7. Endocannabinoid-Binding Receptors as Drug Targets

    Methods in molecular biology (Clifton, N.J.), Vol. 2576, pp. 67-94

  8. Fatty acids fuelling astroglia and beyond

    Nature Metabolism

  9. Functional Characterization of a Familial ALS-Associated Missense TBK1 (p-Arg573Gly) Mutation in Patient-Derived Lymphoblasts

    International Journal of Molecular Sciences, Vol. 24, Núm. 3

  10. Identification of fatty acid amide hydrolase as a metastasis suppressor in breast cancer

    Nature Communications, Vol. 14, Núm. 1

  11. Post-transcriptional control of a stemness signature by RNA-binding protein MEX3A regulates murine adult neurogenesis

    Nature Communications, Vol. 14, Núm. 1